Cargando…

Real World Utilization of Bamlanivimab at a Rural Community Hospital

Introduction Although there were several proposed treatments for patients that were hospitalized with COVID-19, outpatient treatments for those with mild to moderate illness were limited prior to the emergency use authorization (EUA) of virus-neutralizing monoclonal antibodies. To assess the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leavitt, Rachael, Ash, Jordan, Hasenbalg, Phillip, Santarelli, Anthony, Dietrich, Tyson, Schritter, Sarah, Wells, James, Dawson, Adam, Ashurst, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Emergency Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684798/ https://www.ncbi.nlm.nih.gov/pubmed/34938624 http://dx.doi.org/10.7759/cureus.19747

Ejemplares similares

Real world utilization of REGEN-COV2 at a community hospital
por: Ash, Jordan, et al.
Publicado: (2021)

Incidence of Non-thrombotic Diagnoses Following Venous Duplex Ultrasound at a Community Emergency Department
por: Hasenbalg, Bailey, et al.
Publicado: (2021)

Analysis of Smoking Behavior in Patients With Peritonsillar Abscess: A Rural Community Hospital's Experience
por: Clark, Chelsea, et al.
Publicado: (2022)

Gender Differences in Language of Standardized Letter of Evaluation Narratives in Osteopathic Emergency Medicine Residency Applicants
por: Truong, Justina, et al.
Publicado: (2021)

Efficacy of Bamlanivimab in Reducing Hospitalization and Mortality Rates in COVID-19 Patients in a Rural Community
por: Iqbal, Leena, et al.
Publicado: (2021)

500. A Real-World Cohort Study of Bamlanivimab Versus Bamlanivimab-Etesevimab for Non-severe COVID-19
por: Monday, Lea, et al.
Publicado: (2021)

The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting
por: Corwin, Douglas S, et al.
Publicado: (2021)

Real-World Experience of Bamlanivimab for Coronavirus Disease 2019 (COVID-19): A Case-Control Study
por: Kumar, Rebecca N, et al.
Publicado: (2021)

Impact of a Pharmacist-driven Methicillin-resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Swab Protocol on the De-escalation of Empiric Vancomycin in Patients with Pneumonia in a Rural Healthcare Setting
por: Dadzie, Precious, et al.
Publicado: (2019)

A Comparison of Inhaled Epoprostenol in Patients With Acute Respiratory Distress Syndrome and COVID-19-Associated Acute Respiratory Distress Syndrome
por: Robinson, John, et al.
Publicado: (2022)

BAMLANIVIMAB-INDUCED GUILLAIN-BARRÉ SYNDROME
por: PALAGUACHI, GLADYS, et al.
Publicado: (2021)

Early Administration of Bamlanivimab in Combination with Etesevimab Increases the Benefits of COVID-19 Treatment: Real-World Experience from the Liguria Region
por: Vena, Antonio, et al.
Publicado: (2021)

64 Progression of COVID-19 from Urban to Rural Areas in the Southwest: A Spatiotemporal Analysis of Prevalence Rates
por: Ashurst, J., et al.
Publicado: (2021)

What Are the Real-World Podcast-Listening Habits of Medical Professionals?
por: Roland, Damian, et al.
Publicado: (2021)

Bamlanivimab: Guillain-Barre syndrome: case report
Publicado: (2021)

Bamlanivimab: New-onset seizures: case report
Publicado: (2022)

Tethered Cord Syndrome
por: Catmull, Shawn, et al.
Publicado: (2019)

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
por: Dougan, Michael, et al.
Publicado: (2021)

Bamlanivimab infusion experience at one academic emergency department
por: Yoo, Michael J., et al.
Publicado: (2022)

Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19
por: Destras, Grégory, et al.
Publicado: (2021)

Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together
por: Zhang, Lin, et al.
Publicado: (2021)

Eagle Syndrome
por: Bremmer, Elisha, et al.
Publicado: (2018)

Disseminated Gonorrhea
por: Estrada, Janelle, et al.
Publicado: (2019)

Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients
por: Jan, Muhammad Y., et al.
Publicado: (2021)

National Institutes of Health Funding in Internal Medicine: Analysis of Physicians Receiving an R01 Grant Between 2008 and 2017
por: Berg, Erich J, et al.
Publicado: (2021)

Moyamoya: A Rare Cause of Cerebral Vascular Accident
por: Merritt, Brian, et al.
Publicado: (2017)

A Real-World Experience of Hyperkalemia Management Using Sodium Zirconium Cyclosilicate in Chronic Hemodialysis: A Multicenter Clinical Audit
por: Qu, XiaoJie, et al.
Publicado: (2023)

Prehospital Surgical Airway Management Skills in a Rural Emergency Medical Service System
por: Risavi, Brian L, et al.
Publicado: (2023)

Differences in emergency nurse triage between a simulated setting and the real world, post hoc analysis of a cluster randomised trial
por: Morreel, Stefan, et al.
Publicado: (2022)

542. Use of Bamlanivimab in Cancer Patients with Mild-to-Moderate COVID-19
por: Brock, Patricia, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on Emergency Department Transfers to a Higher Level of Care
por: Lee, Stephen, et al.
Publicado: (2021)

Streptococcus gordonii: A Rare Cause of Infective Endocarditis
por: Mosailova, Natalia, et al.
Publicado: (2019)

Extended-Interval Gentamicin Dosing for Pulmonic Tularemia
por: Dietrich, Tyson, et al.
Publicado: (2019)

Accuracy of Weight Estimation Using the Broselow Tape in a Peruvian Pediatric Population
por: Oommen, Jerry Z, et al.
Publicado: (2021)

Secondary Syphilis
por: Ehlers, Sarah, et al.
Publicado: (2020)

Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection
por: Bavaro, DF, et al.
Publicado: (2022)

Frontal Mucopyocoele Presenting With Recurrent Periorbital Cellulitis: A Delayed Diagnosis
por: Ash, Javier, et al.
Publicado: (2022)

A Multimodal Evaluation of an Emergency Department Electronic Tracking Board Utility Designed to Optimize Stretcher Utilization
por: Chisholm, Dirk, et al.
Publicado: (2020)

Development of a Bamlanivimab Infusion Process in the Emergency Department for Outpatient COVID-19 Patients
por: Pham, Danny H., et al.
Publicado: (2021)

First‐in‐Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID‐19
por: Chen, Peter, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6hdcculitmfhtgv8ddlcc8hohj